Jim Tananbaum is the founder and CEO of Foresite Capital, which invests at the intersection of biology, computation, and healthcare. He founded the firm in 2011 after co-founding GelTex Pharmaceuticals, Theravance, and Prospect Venture Partners. His investing and company-building work includes 10x Genomics, Insitro, and Xaira Therapeutics.
Jim Tananbaum is the founder and CEO of Foresite Capital, which invests at the intersection of biology, computation, and healthcare. He founded the firm in 2011 after co-founding GelTex Pharmaceuticals, Theravance, and Prospect Venture Partners. His investing and company-building work includes 10x Genomics, Insitro, and Xaira Therapeutics.
Career
Founder & CEO at Foresite Capital until Present